Polymorphisms in the glutamate decarboxylase 1 gene associated with heroin dependence

Biochemical and Biophysical Research Communications

Volumn 422, Issue 1, 2012, Pages 91-96

  Wu, W ^a,b   Zhu, Y S ^a,b,c   Li, S B ^a,b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Key Laboratory of Ministry of Public Health for Forensic Science   (China)

^c NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Glutamic acid decarboxylase gene 1; Heroin dependence; Single nucleotide polymorphisms

Indexed keywords

GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 67;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; GENETIC MARKERS; GLUTAMATE DECARBOXYLASE; HEROIN DEPENDENCE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; YOUNG ADULT;

EID: 84861457276     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.04.112     Document Type: Article

References (28)

1. van den Bree M.B., Johnson E.O., Neale M.C., Pickens R.W. Genetic and environmental influences on drug use and abuse/dependence in male and female twins. Drug Alcohol Depend. 1998, 52:231-241.
2. Uhl G.R. Molecular genetics of substance abuse vulnerability: remarkable recent convergence of genome scan results. Ann. NY Acad. Sci. 2004, 1025:1-13.
3. Uhl G.R., Drgon T., Johnson C., Fatusin O.O., Liu Q.R., Contoreggi C., Li C.Y., Buck K., Crabbe J. "Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice. Biochem. Pharmacol. 2008, 75:98-111.
4. Kuo P.H., Kalsi G., Prescott C.A., Hodgkinson C.A., Goldman D., Alexander J., van den Oord E.J., Chen X., Sullivan P.F., Patterson D.G., Walsh D., Kendler K.S., Riley B.P. Associations of glutamate decarboxylase genes with initial sensitivity and age-at-onset of alcohol dependence in the Irish Affected Sib Pair Study of Alcohol Dependence. Drug Alcohol Depend. 2009, 101:80-87.
5. Levran O., Londono D., O'Hara K., Randesi M., Rotrosen J., Casadonte P., Linzy S., Ott J., Adelson M., Kreek M.J. Heroin addiction in African Americans: a hypothesis-driven association study. Genes Brain Behav. 2009, 8:531-540.
6. Soghomonian J.J., Martin D.L. Two isoforms of glutamate decarboxylase: why?. Trends Pharmacol. Sci. 1998, 19:500-505.
7. Asada H., Kawamura Y., Maruyama K., Kume H., Ding R., Ji F.Y., Kanbara N., Kuzume H., Sanbo M., Yagi T., Obata K. Mice lacking the 65kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures. Biochem. Biophys. Res. Commun. 1996, 229:891-895.
8. Kash S.F., Tecott L.H., Hodge C., Baekkeskov S. Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. USA 1999, 96:1698-1703.
9. Eravci M., Schulz O., Grospietsch T., Pinna G., Brodel O., Meinhold H., Baumgartner A. Gene expression of receptors and enzymes involved in GABAergic and glutamatergic neurotransmission in the CNS of rats behaviourally dependent on ethanol. Br. J. Pharmacol. 2000, 131:423-432.
10. Zhang X., Lee T.H., Xiong X., Chen Q., Davidson C., Wetsel W.C., Ellinwood E.H. Methamphetamine induces long-term changes in GABAA receptor alpha2 subunit and GAD67 expression. Biochem. Biophys. Res. Commun. 2006, 351:300-305.
11. de Azeredo L.A., Marquardt A.R., Frazzon A.P., Barros H.M. Cocaine reverses the changes in GABAA subunits and in glutamic acid decarboxylase isoenzymes mRNA expression induced by neonatal 6-hydroxydopamine. Behav. Pharmacol. 2010, 21:343-352.
12. Satta R., Maloku E., Zhubi A., Pibiri F., Hajos M., Costa E., Guidotti A. Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons. Proc. Natl. Acad. Sci. USA 2008, 105:16356-16361.
13. Carta A.R., Moreno C.C., Cadoni C., Tronci E., Di Chiara G. Long-term increase in GAD67 mRNA expression in the central amygdala of rats sensitized by drugs and stress. Eur. J. Neurosci. 2008, 27:1220-1230.
14. Loh el W., Lane H.Y., Chen C.H., Chang P.S., Ku L.W., Wang K.H., Cheng A.T. Glutamate decarboxylase genes and alcoholism in Han Taiwanese men. Alcohol. Clin. Exp. Res. 2006, 30:1817-1823.
15. Terranova C., Tucci M., Forza G., Barzon L., Palu G., Ferrara S.D. Alcohol dependence and glutamate decarboxylase gene polymorphisms in an Italian male population. Alcohol 2010, 44:407-413.
16. Lundorf M.D., Buttenschon H.N., Foldager L., Blackwood D.H., Muir W.J., Murray V., Pelosi A.J., Kruse T.A., Ewald H., Mors O. Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 135B:94-101.
17. Du J., Duan S., Wang H., Chen W., Zhao X., Zhang A., Wang L., Xuan J., Yu L., Wu S., Tang W., Li X., Li H., Feng G., Xing Q., He L. Comprehensive analysis of polymorphisms throughout GAD1 gene: a family-based association study in schizophrenia. J. Neural Transm. 2008, 115:513-519.
18. Chang S.C., Pauls D.L., Lange C., Sasanfar R., Santangelo S.L. Common genetic variation in the GAD1 gene and the entire family of DLX homeobox genes and autism spectrum disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2011, 156:233-239.
19. Utge S., Soronen P., Partonen T., Loukola A., Kronholm E., Pirkola S., Nyman E., Porkka-Heiskanen T., Paunio T. A population-based association study of candidate genes for depression and sleep disturbance. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:468-476.
20. Russo S.J., Festa E.D., Fabian S.J., Gazi F.M., Kraish M., Jenab S., Quinones-Jenab V. Gonadal hormones differentially modulate cocaine-induced conditioned place preference in male and female rats. Neuroscience 2003, 120:523-533.
21. Straub R.E., Lipska B.K., Egan M.F., Goldberg T.E., Callicott J.H., Mayhew M.B., Vakkalanka R.K., Kolachana B.S., Kleinman J.E., Weinberger D.R. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol. Psychiatry 2007, 12:854-869.
22. Marenco S., Savostyanova A.A., van der Veen J.W., Geramita M., Stern A., Barnett A.S., Kolachana B., Radulescu E., Zhang F., Callicott J.H., Straub R.E., Shen J., Weinberger D.R. Genetic modulation of GABA levels in the anterior cingulate cortex by GAD1 and COMT. Neuropsychopharmacology 2010, 35:1708-1717.
23. Xi Z.X., Stein E.A. Increased mesolimbic GABA concentration blocks heroin self-administration in the rat. J. Pharmacol. Exp. Ther. 2000, 294:613-619.
24. Caille S., Parsons L.H. Intravenous heroin self-administration decreases GABA efflux in the ventral pallidum: an in vivo microdialysis study in rats. Eur. J. Neurosci. 2004, 20:593-596.
25. Nackley A.G., Shabalina S.A., Tchivileva I.E., Satterfield K., Korchynskyi O., Makarov S.S., Maixner W., Diatchenko L. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006, 314:1930-1933.
26. Veyrieras J.B., Kudaravalli S., Kim S.Y., Dermitzakis E.T., Gilad Y., Stephens M., Pritchard J.K. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 2008, 4:e1000214.
27. Kundakovic M., Chen Y., Costa E., Grayson D.R. DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol. Pharmacol. 2007, 71:644-653.
28. Kundakovic M., Chen Y., Guidotti A., Grayson D.R. The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes. Mol. Pharmacol. 2009, 75:342-354.